Who owns AVEO Pharmaceuticals?

Key details on AVEO Pharmaceuticals (Ticker: AVEO)

Who owns AVEO Pharmaceuticals?

Is AVEO a good stock to own? Find out who bought AVEO Pharmaceuticals, who sold AVEO Pharmaceuticals (AVEO) stock, and who holds a large position in AVEO Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
Baupost 3.83M $7.01M Dec. 31, 2013
BlackRock Institutional Trust Company, N.A. 3.74M $6.85M Dec. 31, 2013
ALLIANCEBERNSTEIN 2.10M $26.09M March 31, 2012
Palo Alto Investors 1.43M $2.62M Dec. 31, 2013
BlackRock Fund Advisors 1.42M $2.61M Dec. 31, 2013
MPM Asset Management 1.37M $2.51M Dec. 31, 2013
Renaissance Technologies 1.31M $2.70M Sept. 30, 2013
Vanguard 1.31M $2.41M Dec. 31, 2013
D. E. Shaw & Co 925254 $1.70M Dec. 31, 2013
TCW 908419 $9.46M Sept. 30, 2012
FMR 870455 $1.60M Dec. 31, 2013
Credit Suisse AG 841034 $2.10M June 30, 2013
Technical Financial Services 833762 $1.72M Sept. 30, 2013
STATE STREET CORPORATION 740836 $1.36M Dec. 31, 2013
NORTHERN TRUST 716756 $1.30M Dec. 31, 2013
GRANAHAN INVESTMENT MANAGEMENT INC/MA 676451 $1.01M March 31, 2014
Deer VI & Co 675242 $1.24M Dec. 31, 2013
OppenheimerFunds 598602 $7.43M March 31, 2012
Greylock XI GP Limited Partnership 584004 $876006 March 31, 2014
Oracle Investment Management 575000 $1.18M Sept. 30, 2013
JPMORGAN CHASE & CO 554235 $6.73M June 30, 2012
Deutsche Bank Aktiengesellschaft 550694 $1.01M Dec. 31, 2013
Wellington Management Company 549539 $1.14M Sept. 30, 2013
Royce & Associates 540000 $1.35M June 30, 2013
Baker Bros. Advisors 519833 $3.82M March 31, 2013
BlackRock Advisors 454451 $936169 Sept. 30, 2013
Black Horse Capital Management 410694 $7.06M Dec. 31, 2011
Visium Asset Management 400000 $736000 Dec. 31, 2013
DIMENSIONAL FUND ADVISORS 389637 $716932 Dec. 31, 2013
S.A.C. Capital Advisors 377123 $4.59M June 30, 2012
Absolute Return Capital, LLC* 362896 $907240 June 30, 2013
Adage Capital Partners GP 350000 $4.34M March 31, 2012
AQR Capital Management 349400 $723258 Sept. 30, 2013

Who sold AVEO Pharmaceuticals?

Fund Name Date Sold Number of Shares Sold Share Valuation
Alyeska Investment Sept. 30, 2011 507902 $7.82M
Driehaus Capital Management Sept. 30, 2011 364606 $5.61M
Sectoral Asset Management June 30, 2011 1.22M $25.23M
OrbiMed Advisors March 31, 2011 405400 $5.40M
Norges Bank Investment Management March 31, 2011 378456 $5.04M
Brookside Capital Management, LLC* Dec. 31, 2010 883958 $12.92M
HealthCor Management Dec. 31, 2010 392000 $5.73M